| Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas MH Tsai, A Raykova, O Klinke, K Bernhardt, K Gärtner, CS Leung, ... Cell reports 5 (2), 458-470, 2013 | 239 | 2013 |
| Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection O Chijioke, A Müller, R Feederle, MHM Barros, C Krieg, V Emmel, ... Cell reports 5 (6), 1489-1498, 2013 | 236 | 2013 |
| CD141+ dendritic cells produce prominent amounts of IFN-α after dsRNA recognition and can be targeted via DEC-205 in humanized mice S Meixlsperger, CS Leung, PC Rämer, M Pack, LD Vanoaica, G Breton, ... Blood, The Journal of the American Society of Hematology 121 (25), 5034-5044, 2013 | 140 | 2013 |
| Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope display CS Leung, TA Haigh, LK Mackay, AB Rickinson, GS Taylor Proceedings of the National Academy of Sciences 107 (5), 2165-2170, 2010 | 125 | 2010 |
| Mice with human immune system components as in vivo models for infections with human pathogens PC Rämer, O Chijioke, S Meixlsperger, CS Leung, C Münz Immunology and cell biology 89 (3), 408-416, 2011 | 70 | 2011 |
| Vaccination against the Epstein–Barr virus J Rühl, CS Leung, C Münz Cellular and Molecular Life Sciences 77, 4315-4324, 2020 | 63 | 2020 |
| Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity MA Maurer, G Rakocevic, CS Leung, I Quast, M Lukačišin, N Goebels, ... The Journal of clinical investigation 122 (4), 1393-1402, 2012 | 63 | 2012 |
| Heterologous prime-boost vaccination protects against EBV antigen–expressing lymphomas J Rühl, C Citterio, C Engelmann, T Haigh, A Dzionek, J Dreyer, R Khanna, ... The Journal of clinical investigation 129 (5), 2071-2087, 2019 | 58 | 2019 |
| Infectious diseases in humanized mice C Leung, O Chijioke, C Gujer, B Chatterjee, O Antsiferova, V Landtwing, ... European journal of immunology 43 (9), 2246-2254, 2013 | 52 | 2013 |
| Robust T-cell stimulation by Epstein-Barr virus–transformed B cells after antigen targeting to DEC-205 CS Leung, MA Maurer, S Meixlsperger, A Lippmann, C Cheong, J Zuo, ... Blood, The Journal of the American Society of Hematology 121 (9), 1584-1594, 2013 | 50 | 2013 |
| Endogenous antigen presentation of MHC class II epitopes through non-autophagic pathways CSK Leung Frontiers in immunology 6, 149927, 2015 | 47 | 2015 |
| T cell detection of a B-cell tropic virus infection: newly-synthesised versus mature viral proteins as antigen sources for CD4 and CD8 epitope display LK Mackay, HM Long, JM Brooks, GS Taylor, CS Leung, A Chen, F Wang, ... PLoS pathogens 5 (12), e1000699, 2009 | 41 | 2009 |
| Animal models of Epstein Barr virus infection B Chatterjee, CS Leung, C Münz Journal of immunological methods 410, 80-87, 2014 | 36 | 2014 |
| Kaposi's sarcoma-associated herpesvirus-encoded viral IRF3 modulates major histocompatibility complex class II (MHC-II) antigen presentation through MHC-II transactivator … J Zuo, AD Hislop, CS Leung, S Sabbah, M Rowe Journal of virology 87 (10), 5340-5350, 2013 | 28 | 2013 |
| Human ZBP1 induces cell death‐independent inflammatory signaling via RIPK3 and RIPK1 R Peng, CK Wang, X Wang‐Kan, M Idorn, M Kjær, FY Zhou, BK Fiil, ... EMBO reports 23 (12), e55839, 2022 | 21 | 2022 |
| Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy J McAuliffe, HF Chan, L Noblecourt, RA Ramirez-Valdez, ... Journal for immunotherapy of cancer 9 (9), 2021 | 14 | 2021 |
| Nuclear shelter: the influence of subcellular location on the processing of antigens by macroautophagy CS Leung, GS Taylor Autophagy 6 (4), 560-561, 2010 | 13 | 2010 |
| ZBP1 induces inflammatory signaling via RIPK3 and promotes SARS-CoV-2-induced cytokine expression R Peng, X Wang-Kan, M Idorn, FY Zhou, SL Orozco, J McCarthy, ... bioRxiv, 2021.10. 01.462460, 2021 | 5 | 2021 |
| Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression RA Ramirez-Valdez, F Baharom, A Khalilnezhad, SC Fussell, ... Cell reports 42 (6), 2023 | 3 | 2023 |
| Combining personalized neoantigen vaccination with chemotherapy and anti-PD-1 to treat NSCLC CSK Leung, BJ Van den Eynde Cancer cell 40 (9), 903-905, 2022 | 2 | 2022 |
